Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Changes in CD4 lymphocyte count after switching tenofovir to abacavir in virally suppressed HIV patients on didanosine + tenofovir
2004-003749-42Phase 3Active
- Sponsor
- Hospital General de Granollers
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of abacavir in human immunodeficiency virus infection (HIV), sponsored by Hospital General de Granollers. Primary endpoint: CD4 cell count. Started Dec 2005; status: active.
02
Drugs
abacavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2004-003749-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003749-42.